跳至主要内容
临床试验/ACTRN12618002026202
ACTRN12618002026202已完成未知

The role of vibration therapy in improving the health and mobility of young children with cerebral palsy.

Prof Paul Hofman0 个研究点目标入组 34 人开始时间: 2018年12月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
5 Years 至 12 Years(—)
性别
All

入选标准

  • Have diagnosed cerebral palsy with GMFCS I - III
  • - Be able to safely stand on the vibration platform
  • - Be able to understand the researcher’s instructions and follow them

排除标准

  • - A bone fracture within 12 weeks of enrolment
  • - Acute thrombosis, tendinitis, nephrolithiasis, discopathy or arthritis
  • - History of clinically significant organic disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study.
  • - History of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrolment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone.
  • - History of botulinum toxin injection into lower limbs within 3 months of enrollment

研究者

发起方
Prof Paul Hofman

相似试验